Progression Free Survival at 12 Months After First-Line Therapy Is Associated With Favourable Outcomes After First Relapse/Progression in Peripheral T-Cell Lymphoma
Hematological Oncology - United Kingdom
doi 10.1002/hon.148_2631
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley